Authors | Publication Year | Location | Study design | Cohort Size | Findings relevant to this section |
Ellenbogen et al.(1) | 2006 | North America | Prospective | 458 | “Appropriate therapy” is an effective proxy of SCD in non-ischaemic cardiomyopathies. |
Azoulay et al.(5)
|
2020
|
Global
|
Retrospective
|
464
|
Statistically significant factors in predicting appropriate therapy are: Young age, male sex, low LVEF, ventricular pacing, complete heart block. Statistically non-significant factors in predicting appropriate therapy are: LBBB/RBBB, positive CMR & syncope |
Taha et al.(6) | 2022 | Global | Retrospective | 530 | (Includes several non-predictors of appropriate therapy, please see main text) |
Schuller et al.(7) | 2012 | North America | Retrospective | 112 | Higher rates of appropriate therapy in those with RV dysfunction. |
Halawa et al.(8) | 2020 | Global | Mixed prospective & retrospective | 585 | Rates of appropriate therapy higher in those with AVB. |
Franke et al.(9) | 2020 | Global | Mixed prospective & retrospective | 1247 | Higher rates of appropriate therapy in those whom ICD was implanted for secondary prevention. |
Mathijssen et al.(10) | 2022 | Netherlands | Retrospective | 105 | Higher rates of appropriate ICD therapy in male sex, 2nd/3rd degree AVB, prior VA, and presence of LGE on CMR – most strongly with LGE in the area of RV. |
Kron et al.(11) | 2013 | North America | Retrospective | 33 | Young age and reduced LVEF predict appropriate ICD therapy. |